This monkey business [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2013-06-13 22:04 (4337 d 22:10 ago) – Posting: # 10781
Views: 10,632

Hi John!

❝ ❝ […] IMHO FDA wants at least 24 subjects.


❝ n≥12 is what FDA wants.


Yes, for 2×2. Do you have a reference that 12 are enough for scaling?

❝ ❝ Hhm, why don’t you save the money (or wire somefink to my bank account instead) and submit the pilot study as pivotal evidence of BE?


❝ I asked the Senior mgt too and they said it's a pilot batch but manufactured with pivotal specification. I don't understand their answer. I will go digging and see if they know what they are talking about.


;-)

❝ ❝ Or the GMR and/or CV go loony and jump around between studies. Wouldn’t surprise me with a CV of 60%…


❝ That's my concern now since we are only 5% away from failing the T/R ratio.


Yes, it will be a close shave.

❝ ❝ Power. That which statisticians are always calculating

❝ ❝ but never have. Stephen Senn


❝ Corporate decision comes first :-|


Sigh.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
20 visitors (0 registered, 20 guests [including 14 identified bots]).
Forum time: 20:15 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5